Yiling Wang Email & Phone Number

Master of Science: Medicinal Chemistry, Expected in 10/2024Rutgers, The State University of New Jersey - New Brunswick, NJMaster of Science: Pharmaceutical Science, 05/2020University of Southern California - Los Angeles, CABachelor of Science: Chemistry, 04/2017University of California, Santa Barbara - Santa Barbara, CA Recent graduate with foundational knowledge in both pharmaceutical science and medicinal chemistry and hands-on experience gained through lab experience. Demonstrates strong teamwork, problem-solving, and time-management skills. Prepared to start career and make meaningful contributions with commitment and drive. 2018-2020 Application of NAD+ analogue in ADC conjugate for therapeutic uses2020-2022 Discovery of L-Cystine crystallization inhibitors 2022-2024 Optimization of prodrugs of calcium oxalate crystallization inhibitors • Laboratory techniques• Analytical chemistry• Scientific Presentation• Drug Discovery• Organic Synthesis• Chromatography Expertise • Medicinal Chemistry• Protein Purification Methods• PCR and qPCR Techniques• Mass Spectrometry Knowledge• In Vitro Assay Development 2021 (1)Cheng, Q., et al. "Expanding the Toolbox of Exosome-Based Modulators of Cell Functions." Biomaterials 277 (2021): 121129. Print.2022 (2)Cheng, Q., et al. "A Poly-Adp-Ribose Polymer-Gcsf Conjugate." Biomacromolecules 23.12 (2022): 5267-72. Print.Zhang, X. N., et al. "Discovery of an Nad(+) Analogue with Enhanced Specificity for Parp1." Chem Sci 13.7 (2022): 1982-91. Print.2023 (2)Cheng, Q., et al. "Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-Adp-Ribose Polymers." Biochemistry 62.6 (2023): 1138-44. Print.Yang, Jeffrey, et al. "Development of Convenient Crystallization Inhibition Assays for Structure-Activity Relationship Studies in the Discovery of Crystallization Inhibitors." Medicinal Chemistry Research 32.7 (2023): 1391-99. Print.2024 (2)Hu, Longqin, et al. "Structure-Activity Relationships and Pharmacokinetic Evaluation of L-Cystine Diamides as L-Cystine Crystallization Inhibitors for Cystinuria." Medicinal Chemistry Research 33.8 (2024): 1384-407. Print.Hu, Longqin, et al. "8-L-Cystinyl Bis(1,8-Diazaspiro[4.5]Decane) as an Orally Bioavailable L-Cystine Crystallization Inhibitor for Cystinuria." ACS Medicinal Chemistry Letters 15.7 (2024): 1026-31. Print.